Nader Rifai

Q: What Schools Are Affiliated With Nader Rifai

Nader Rifai is affiliated with the following schools: McGill University, Drexel University, United States Military Academy, Massachusetts General Hospital, King Abdulaziz University, Duke University, University of Zurich, University of Texas Southwestern Medical Center, University of Cambridge, Harvard University

Nader Rifai's AcademicInfluence.com Rankings

Nader Rifai

Philosophy

#2842

World Rank

#4733

Historical Rank

Logic

#814

World Rank

#1358

Historical Rank

philosophy Degrees

Nader Rifai

Biology

#3391

World Rank

#5197

Historical Rank

Biochemistry

#312

World Rank

#379

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Nader Rifai Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nader Rifai's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. (2000) (6050)
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. (2003) (5024)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (2001) (4267)
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. (2000) (2460)
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women (2003) (2421)
C-reactive protein levels and outcomes after statin therapy. (2005) (2243)
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. (2007) (1720)
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. (2001) (1665)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility (2006) (1657)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. (2002) (1571)
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. (2007) (1547)
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. (1998) (1476)
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein (1999) (1460)
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. (2001) (1405)
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. (2001) (1398)
Multiple biomarkers for the prediction of first major cardiovascular events and death. (2006) (1347)
Plasma adiponectin levels and risk of myocardial infarction in men. (2004) (1211)
Inflammatory markers and the risk of coronary heart disease in men and women. (2004) (1182)
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. (2004) (1070)
Prevalence of the Metabolic Syndrome in American Adolescents: Findings From the Third National Health and Nutrition Examination Survey (2004) (1060)
C-reactive protein and the risk of developing hypertension. (2003) (970)
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. (2000) (958)
Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. (2001) (901)
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men (2008) (839)
Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. (2004) (807)
Inflammatory markers and risk of developing type 2 diabetes in women. (2004) (778)
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men (2004) (777)
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. (2005) (769)
C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy (1998) (762)
Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. (2005) (756)
Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide (2002) (756)
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. (2002) (734)
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. (2001) (688)
Blood Pressure and Inflammation in Apparently Healthy Men (2001) (685)
Clinical efficacy of an automated high-sensitivity C-reactive protein assay. (1999) (668)
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. (2004) (643)
Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. (2004) (608)
Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. (2005) (601)
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. (1999) (593)
Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women (2003) (577)
Soluble P-Selectin and the Risk of Future Cardiovascular Events (2001) (564)
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. (2004) (563)
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. (2001) (563)
Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death (2002) (559)
C-reactive protein and the risk of incident colorectal cancer. (2004) (557)
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. (2005) (526)
Serum aldosterone and the incidence of hypertension in nonhypertensive persons. (2004) (521)
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. (2009) (510)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events (2003) (490)
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med (2016) (489)
Hormone replacement therapy and increased plasma concentration of C-reactive protein. (1999) (484)
Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia (2001) (469)
Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in Women (2002) (463)
Tietz textbook of clinical chemistry and molecular diagnostics (2018) (460)
Dietary intake of trans fatty acids and systemic inflammation in women. (2004) (460)
Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. (2000) (453)
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women (2009) (443)
Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. (2001) (442)
Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach* (2014) (430)
Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. (2001) (428)
Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. (2004) (427)
Association between C-reactive protein and age-related macular degeneration. (2004) (420)
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. (2001) (418)
Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women (2002) (415)
High-sensitivity C-reactive protein: clinical importance. (2004) (411)
High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study (2003) (410)
Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events (2008) (399)
Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. (2002) (391)
Relation between markers of systemic vascular inflammation and smoking in women. (2002) (390)
Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. (1997) (375)
Adiponectin and future coronary heart disease events among men with type 2 diabetes. (2005) (371)
Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events (2003) (360)
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. (2001) (351)
Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease (2007) (347)
Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. (2005) (344)
Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. (2004) (342)
Handbook of Lipoprotein Testing (2001) (334)
Effect of statin therapy on C-reactive protein levels. The pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study☆ (2001) (317)
Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 Women (2008) (303)
Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial Infarction (2008) (302)
Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial (2006) (302)
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. (1998) (301)
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. (2012) (284)
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). (2000) (282)
Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. (1998) (280)
Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial (2003) (273)
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. (2005) (256)
Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. (2003) (253)
Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women (2007) (251)
Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. (2003) (250)
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. (2000) (250)
Androgens and Diabetes in Men (2007) (249)
Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. (2004) (248)
Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. (2004) (244)
Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression (2005) (242)
Multivariate Assessment of Lipid Parameters as Predictors of Coronary Heart Disease Among Postmenopausal Women: Potential Implications for Clinical Guidelines (2004) (242)
Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era (2005) (233)
Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon (1999) (232)
Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men (2002) (231)
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. (2001) (229)
Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. (1996) (223)
Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. (2001) (223)
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. (2004) (222)
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women (2007) (221)
A Prospective Study of C-Peptide, Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-1, and the Risk of Colorectal Cancer in Women (2005) (218)
Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. (1999) (215)
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. (2006) (213)
Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. (2005) (210)
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. (2007) (208)
Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. (1986) (205)
Measurement of low-density-lipoprotein cholesterol in serum: a status report. (1992) (203)
A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. (2007) (203)
Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis In Myocardial Infarction 18) Substudy (2004) (200)
Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors (2012) (195)
C-reactive protein and incident cardiovascular events among men with diabetes. (2004) (194)
C-reactive protein: a nontraditional serum marker of cardiovascular risk. (2007) (192)
Association of markers of insulin and glucose control with subsequent colorectal cancer risk. (2003) (191)
National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. (2009) (188)
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. (2008) (187)
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group (2004) (185)
Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study (2007) (184)
Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. (2004) (181)
Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study (2004) (180)
Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency (2000) (174)
False increase of cardiac troponin I with heterophilic antibodies. (1998) (173)
Multiple Biomarkers and the Risk of Incident Hypertension (2007) (170)
Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. (2009) (170)
C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. (2002) (165)
Lipoprotein(a) and risk of type 2 diabetes. (2010) (164)
Cardiac troponin increases among runners in the Boston Marathon. (2007) (164)
Association between dietary factors and plasma adiponectin concentrations in men. (2005) (163)
Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes (1999) (161)
Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. (2006) (161)
C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. (2003) (159)
Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. (2006) (158)
A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. (2010) (155)
Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. (2001) (155)
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medi (2016) (151)
Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease: A Cohort Study (2008) (149)
Valsartan, Blood Pressure Reduction, and C-Reactive Protein: Primary Report of the Val-MARC Trial (2006) (149)
Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men (2009) (148)
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM. (2018) (148)
Long-Term Prognostic Value of Neopterin: A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome (2007) (146)
Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. (2009) (146)
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. (2000) (144)
Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. (1998) (144)
Inflammatory markers in men with angiographically documented coronary heart disease. (1999) (144)
Circulating Levels of Endothelial Adhesion Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of Women (2007) (144)
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. (2000) (140)
The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. (2005) (138)
Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. (2006) (138)
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. (2000) (132)
Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk (2008) (129)
Sex steroid hormone concentrations and risk of death in US men. (2010) (128)
Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. (2000) (128)
Circulating Levels of Resistin and Risk of Type 2 Diabetes in Men and Women: Results From Two Prospective Cohorts (2009) (127)
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. (2005) (127)
Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. (2004) (122)
Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. (1999) (121)
Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System: The Framingham Heart Study (2008) (119)
Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus: The Women's Health Study (2011) (118)
Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. (2003) (117)
Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. (2009) (116)
Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. (1998) (114)
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity (2001) (114)
Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. (2004) (114)
Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial (2005) (112)
Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method. (1998) (112)
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM (2019) (111)
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. (2013) (109)
Role of free radicals in cancer and atherosclerosis. (1993) (106)
Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer (2011) (106)
Body iron stores and their determinants in healthy postmenopausal US women. (2003) (103)
D-Dimer, Inflammatory Markers, and Lower Extremity Functioning in Patients With and Without Peripheral Arterial Disease (2003) (100)
Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. (2004) (98)
Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial (2008) (98)
Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. (2013) (98)
Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III). (2007) (97)
Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. (2002) (93)
High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. (2000) (93)
Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease (2015) (93)
Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men (2004) (92)
Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. (2002) (91)
Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. (2011) (91)
Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials. (2003) (91)
Body fatness and sex steroid hormone concentrations in US men: results from NHANES III (2011) (91)
Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women? (2006) (90)
Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. (2008) (89)
Incidence of Lead Poisoning in Young Children from Inner‐City, Suburban, and Rural Communities (1993) (89)
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Choleste (2009) (87)
Effects of exercise training on cardiovascular function and plasma lipid, lipoprotein, and apolipoprotein concentrations in premenopausal and postmenopausal women. (1991) (86)
Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. (2007) (86)
Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. (2003) (86)
Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. (1999) (86)
Erratum: Androgens and diabetes in men: Results from the Third National Health and Nutrition Examination Survey (NHANES III). (Diabetes Care (2007) 30, (234-238)) (2007) (86)
Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia. (2002) (86)
Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. (2007) (85)
Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events (2006) (85)
Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. (2005) (85)
Inflammatory markers and coronary heart disease (2002) (84)
Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events. (2016) (84)
Effects of a single bout of ultraendurance exercise on lipid levels and susceptibility of lipids to peroxidation in triathletes. (1996) (84)
Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women. (2001) (84)
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. (1998) (83)
What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema (2010) (83)
Is C-Reactive Protein Specific for Vascular Disease in Women? (2002) (83)
Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activity. (1995) (83)
Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men (2001) (81)
Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. (2007) (80)
High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. (2007) (80)
C-Peptide, Insulin-like Growth Factor Binding Protein-1, Glycosylated Hemoglobin, and the Risk of Distal Colorectal Adenoma in Women (2006) (80)
Hyperlipemic Response of Young Trained and Untrained Men after a High Fat Meal (1989) (79)
Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study (2013) (79)
Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. (2007) (78)
Inflammation, the Acute Phase Response and Atherosclerosis (1999) (76)
Impact of Vitamin D Supplementation on Inflammatory Markers in African Americans: Results of a Four-Arm, Randomized, Placebo-Controlled Trial (2013) (76)
Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. (2005) (74)
Gender differences in exercise-induced changes in sex hormone levels and lipid peroxidation in athletes participating in the Hawaii Ironman triathlon. Ginsburg-gender and exercise-induced lipid peroxidation. (2001) (74)
Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. (2007) (73)
Postprandial Effect of a High Fat Meal on Plasma Lipid, Lipoprotein Cholesterol and Apolipoprotein Measurements (1990) (73)
Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation. (2000) (70)
Adipocytokines, Inflammation, and Breast Cancer Risk in Postmenopausal Women: A Prospective Study (2013) (69)
International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibrators. (1998) (69)
Soluble Intercellular Adhesion Molecules, Soluble Vascular Cell Adhesion Molecules, and Risk of Coronary Heart Disease (2006) (69)
The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. (2006) (69)
Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study (2007) (66)
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. (2020) (65)
Plasma leptin concentrations and four-year weight gain among US men (2001) (65)
Pediatric reference ranges on the Abbott IMx for FSH, LH, prolactin, TSH, T4, T3, free T4, free T3, T-uptake, IgE, and ferritin. (1995) (65)
Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States) (1999) (64)
Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men (2000) (64)
High Sensitivity Immunoassays for C-Reactive Protein: Promises and Pitfalls (2001) (64)
Circulating Blood Markers and Functional Impairment in Peripheral Arterial Disease (2008) (63)
Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. (2002) (62)
Metabolic syndrome components and colorectal adenoma in the CLUE II cohort (2009) (62)
Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. (2005) (62)
Stability of measurements of biomarkers of oxidative stress in blood over 36 hours. (2004) (61)
The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. (2002) (61)
Three routine methods for measuring high-density lipoprotein cholesterol compared with the Reference Method. (1996) (61)
Failure of current guidelines for cholesterol screening in urban African-American adolescents. (1996) (61)
The riddle of protein diagnostics: future bleak or bright? (2013) (60)
C-reactive protein and coronary heart disease (2007) (60)
Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer (2011) (60)
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. (2010) (59)
A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. (2008) (59)
Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. (2001) (59)
Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory. (2002) (58)
Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women. (2003) (58)
Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes. (2003) (57)
Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial. (2020) (57)
High Sensitivity C-reactive Protein: An Emerging Role in Cardiovascular Risk Assessment (2002) (57)
Hormonal profile of diabetic men and the potential link to prostate cancer (2008) (56)
Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies. (2007) (56)
Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? (2005) (56)
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipoprotein(a). Phase 2: Selection and Properties of a Proposed Secondary Reference Material for Lipoprotein(a). (1999) (56)
Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. (2000) (55)
Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay. (1998) (54)
D‐Dimer and Inflammatory Markers as Predictors of Functional Decline in Men and Women with and without Peripheral Arterial Disease (2005) (54)
Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate-Mg2+ method. (1997) (53)
Stress reactivity and exercise training in premenopausal and postmenopausal women. (1991) (53)
Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease (2015) (53)
A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. (2003) (53)
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). (2011) (52)
Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III) (2012) (52)
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. (2007) (52)
Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men. (2005) (52)
Reporting bias in diagnostic and prognostic studies: time for action. (2008) (52)
Vitamin A status in acute exacerbations of cystic fibrosis. (1996) (52)
Effect of vitamin supplementation to HIV-infected pregnant women on the micronutrient status of their infants (2005) (52)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events☆ (2003) (52)
Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population. (1996) (51)
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. (2001) (51)
Increased inflammatory markers in children with familial hypercholesterolaemia (2006) (51)
How to use C-reactive protein in acute coronary care. (2013) (50)
Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. (2000) (50)
Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. (2006) (49)
No association between pre‐diagnostic plasma C‐reactive protein concentration and subsequent prostate cancer (2004) (49)
Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial. (2012) (49)
Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men (2009) (48)
The Effect of Low‐Dose Hydrochlorothiazide on Blood Pressure, Serum Potassium, and Lipoproteins (1986) (48)
Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. (2003) (48)
Interleukin-6 Receptor Gene, Plasma C-Reactive Protein, and Diabetes Risk in Women (2009) (47)
Mechanisms and Biomarkers of Cardiovascular Injury Induced by Phosphodiesterase Inhibitor III SK&F 95654 in the Spontaneously Hypertensive Rat (2006) (47)
Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies (2015) (46)
Alcohol Consumption Patterns and HbA1c, C-Peptide and Insulin Concentrations in Men (2003) (46)
The Pharmacokinetics of Epidural Ropivacaine in Infants and Young Children (2001) (46)
Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes (2004) (46)
The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III) (2011) (45)
Acute changes in serum lipids and lipoprotein subclasses in triathletes as assessed by proton nuclear magnetic resonance spectroscopy. (1999) (45)
Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. (2012) (44)
Racial Variation in Sex Steroid Hormones and the Insulin-Like Growth Factor Axis in Umbilical Cord Blood of Male Neonates (2009) (44)
Inflammatory markers and coronary heart disease. (2002) (44)
Interleukin-6 Receptor Gene Variations, Plasma Interleukin-6 Levels, and Type 2 Diabetes in U.S. Women (2007) (43)
Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. (2008) (43)
Early High Dose Antioxidant Vitamins Do Not Prevent Bronchopulmonary Dysplasia in Premature Baboons Exposed to Prolonged Hyperosia: APilot Study (1998) (42)
Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer. (2006) (42)
Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats (1989) (42)
Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. (1987) (42)
Excessive body iron stores are not associated with risk of coronary heart disease in women. (2008) (41)
AHA / CDC Scientific Statement Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice : A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association (2003) (41)
HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. (2005) (41)
Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. (2009) (40)
HPLC measurement, blood distribution, and pharmacokinetics of oral clotrimazole, potentially useful antisickling agent. (1995) (40)
Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns. (2008) (40)
Circulating Adipocytokines and Chronic Kidney Disease (2013) (40)
Urinary N-acetyl-beta-glucosaminidase and beta-2-microglobulin in the diagnosis of urinary tract infection in febrile infants. (1994) (40)
Blood lead and hemoglobin levels in Andean children with chronic lead intoxication. (2000) (39)
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies (2010) (39)
Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death. (2009) (39)
Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men. (2007) (39)
Elevated Plasma Levels of Endostatin Are Associated with Chronic Kidney Disease (2012) (38)
Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls. (2000) (37)
Plasma inflammatory cytokines and survival of pancreatic cancer patients (2018) (37)
Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. (2016) (37)
Frequent Intake of Tropical Fruits That Are Rich in β-Cryptoxanthin Is Associated with Higher Plasma β-Cryptoxanthin Concentrations in Costa Rican Adolescents (2002) (37)
An Increase in Dietary Quality Is Associated with Favorable Plasma Biomarkers of the Brain-Adipose Axis in Apparently Healthy US Women. (2016) (36)
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16 (2008) (36)
Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men (2012) (36)
Biochemical effects of 17β-estradiol on UMR106 cells (1989) (35)
Performance characteristics of a point of care C-reactive protein assay. (2001) (35)
Biomarker discovery and validation. (2006) (35)
A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. (2006) (34)
Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. (2005) (34)
High-sensitivity C-reactive protein: a useful marker for cardiovascular disease risk prediction and the metabolic syndrome. (2005) (34)
Association between serum 25‐hydroxyvitamin D and serum sex steroid hormones among men in NHANES (2016) (33)
Direct measurement of LDL-C in children: performance of two surfactant-based methods in a general pediatric population. (2000) (33)
Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22). (2006) (33)
Plasma adrenal androgens and risk of breast cancer in premenopausal women. (2004) (32)
C-reactive protein and colorectal adenoma in the CLUE II cohort (2008) (32)
Common Variants of the Endothelial Nitric Oxide Synthase Gene and the Risk of Coronary Heart Disease Among U.S. Diabetic Men (2006) (32)
Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis (2001) (31)
Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method. (2000) (31)
Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. (1988) (31)
Serum lipids, neuroendocrine, and cardiovascular responses to stress in men and women with mild hypertension. (1994) (31)
Review of serum lipids and apolipoproteins in risk-assessment of coronary heart disease. (1988) (31)
Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism. (2007) (30)
Inflammatory Plasma Markers and Pancreatic Cancer Risk: A Prospective Study of Five U.S. Cohorts (2013) (30)
Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men (2009) (30)
Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. (1997) (29)
Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers (2005) (29)
Measurement of plasma busulfan concentration by high-performance liquid chromatography with ultraviolet detection. (1997) (29)
High-sensitivity C-reactive protein (2004) (28)
A simple immunotechnique for the determination of serum concentration of apolipoprotein E. (1987) (26)
Tandem Mass Spectrometry Method for the Quantification of Serum Busulfan (2005) (26)
Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women. (2011) (26)
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes (2005) (26)
Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women. (2013) (25)
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. (2000) (25)
Biochemical Basis of Pediatric Disease (1992) (25)
The association of urinary cadmium with sex steroid hormone concentrations in a general population sample of US adult men (2008) (25)
Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial. (2003) (25)
No Effect of β-Carotene Supplementation on Risk of Nonmelanoma Skin Cancer among Men with Low Baseline Plasma β-Carotene (2004) (24)
Commercial immunoassays in biomarkers studies: researchers beware! (2012) (24)
Vitamin C in premature and full-term human neonates. (1996) (24)
The use of multiplex PCR for the diagnosis of viral severe acute respiratory infection in children: a high rate of co-detection during the winter season (2016) (23)
High‐sensitivity C‐reactive protein, adiposity, and blood pressure in the Yakut of Siberia (2006) (23)
Association between sex steroid hormones and hematocrit in a nationally representative sample of men. (2012) (23)
The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines. (1996) (22)
New developments in the biochemical assessment of myocardial injury in children: troponins T and I as highly sensitive and specific markers of myocardial injury (1997) (22)
Publication ethics: clinical chemistry editorial standards. (2009) (22)
Racial variation in vitamin D cord blood concentration in white and black male neonates (2012) (21)
Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women (2005) (21)
A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women (2008) (21)
A New Therapeutic Approach for Sickle Cell Disease (1995) (21)
Simultaneous Measurement of Plasma Ropivacaine and Bupivacaine Concentrations by HPLC with UV Detection (2001) (21)
Standardization of high-sensitivity immunoassays for measurement of C-reactive protein; II: Two approaches for assessing commutability of a reference material. (2009) (21)
Immunoturbidimetry: an attractive technique for the determination of urinary albumin and transferrin. (1987) (21)
A multiplex immunoassay gives different results than singleplex immunoassays which may bias epidemiologic associations. (2012) (21)
Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients. (2003) (21)
A message from the laboratory community to the National Cholesterol Education Program Adult Treatment Panel IV. (2012) (20)
Nonfasting Sample for the Determination of Routine Lipid Profile: Is It an Idea Whose Time Has Come? (2016) (20)
Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III (2010) (20)
Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIII. (1986) (20)
A preliminary study of urinary transferrin as a marker for prostatic cancer. (1986) (19)
Plasma dehydroepiandrosterone and risk of myocardial infarction in women. (2008) (19)
A High‐Performance Liquid Chromatographic Assay for the Determination of Itraconazole Concentration Using Solid‐Phase Extraction and Small Sample Volume (1995) (19)
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy (2022) (19)
Alcohol consumption and high-density lipoprotein levels: the effect of ADH1C genotype, gender and menopausal status. (2005) (18)
Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study. (2004) (18)
Apolipoprotein E is Released by Rat Sciatic Nerve During Segmental Demyelination and Remyelination (1987) (18)
Quality specifications and the assessment of the biochemical risk of atherosclerosis. (2004) (17)
Registering diagnostic and prognostic trials of tests: is it the right thing to do? (2014) (17)
E-selectin genotypes and risk of type 2 diabetes in women. (2005) (17)
Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men. (2010) (17)
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). (2007) (16)
Frequent intake of tropical fruits that are rich in beta-cryptoxanthin is associated with higher plasma beta-cryptoxanthin concentrations in Costa Rican adolescents. (2002) (16)
Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats (2007) (16)
Prolonged survival in pyruvate carboxylase deficiency: lack of correlation with enzyme activity in cultured fibroblasts. (1995) (16)
Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer (2019) (16)
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes (2005) (16)
Clinical Chemistry journal has contributed to progress in lipid and lipoprotein testing for fifty years. (2004) (16)
Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study. (2009) (16)
Use of a rapid HPLC assay for determination of pharmacokinetic parameters of ibuprofen in patients with cystic fibrosis. (1996) (15)
Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children? (1990) (15)
Association between C-Peptide Concentration and Prostate Cancer Incidence in the CLUE II Cohort Study (2010) (15)
Frequency of clinically unsuspected myocardial injury at a children's hospital. (2006) (15)
Markers of the Acute Phase Response in Cardiovascular Disease: An Update (2001) (15)
Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (T (2010) (15)
A New Liquid Homogeneous Assay for HDL Cholesterol Determination Evaluated in Seven Laboratories in Europe and the United States (1999) (15)
Clinical Chemistry: A Glimpse into the Future (2007) (15)
Utility of direct measurement of low-density lipoprotein cholesterol in dyslipidemic pediatric patients. (1998) (14)
Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates (2012) (14)
Plasma adiponectin and the risk of hypertension in white and black postmenopausal women. (2012) (13)
Associations of the apolipoprotein A 1 / C 3 / A 4 / A 5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes (2006) (13)
C-reactive protein and cardiovascular risk in the Framingham Study. (2006) (13)
No effect of beta-carotene supplementation on risk of nonmelanoma skin cancer among men with low baseline plasma beta-carotene. (2004) (13)
Rapid and simple tandem mass spectrometry method for determination of serum cotinine concentration. (2004) (13)
Point: high-sensitivity C-reactive protein and cardiac C-reactive protein assays: is there a need to differentiate? (2006) (13)
Comparative analysis of zinc protoporphyrin and blood lead levels in lead-exposed Andean children. (2007) (13)
Effect of atorvastatin on C-reactive protein in patients with acute coronary syndromes: a substudy of the MIRACL trial (2002) (13)
Disruptive Innovation in Laboratory Medicine. (2015) (13)
Measurement of felbamate by wide-bore capillary gas chromatography and flame ionization detection. (1994) (12)
Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. (2012) (12)
Measurement of antidepressants using solid-phase extraction and wide-bore capillary gas chromatography with nitrogen-selective detection. (1988) (12)
Hemoglobin "Hope" interferes with measurement of glycated hemoglobin by ion-exchange chromatography and electrophoresis. (1984) (12)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. (2012) (12)
An appeal to medical journal editors: The need for a full description of laboratory methods and specimen handling in clinical study reports (2012) (12)
Determination of Serum Physiological Concentration of Methylmalonic Acid by Gas Chromatography-Mass Spectrometry with Selected Ion Monitoring (1998) (11)
Preparation of manuscripts for publication: improving your chances for success. (2009) (11)
Evaluation of an enzymatic homocysteine assay for the Hitachi series chemistry analyzer. (2005) (11)
Intercellular Adhesion Molecule 1 (ICAM1) Lys56Met and Gly241Arg Gene Variants, Plasma-Soluble ICAM1 Concentrations, and Risk of Incident Cardiovascular Events in 23 014 Initially Healthy White Women (2007) (11)
Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran (1998) (11)
Inhibition of the renin-angiotensin system reduces the rise in serum aldosterone in acute coronary syndrome patients with preserved left ventricular function: observations from the AVANT GARDE-TIMI 43 trial. (2013) (11)
Inflammatory biomarkers, aspirin, and risk of colorectal cancer: Findings from the physicians' health study. (2016) (10)
Expanding options for scientific publication: is more always better? (2013) (10)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. (2012) (10)
HbA1c Predicts Diabetes but not Cardiovascular Disease in Non- Diabetic Women (2008) (10)
Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents. (2000) (10)
A girl with goiter and inappropriate thyroid-stimulating hormone secretion. (2008) (10)
Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial (2012) (10)
Commercial immunoassays in biomarkers studies: researchers beware! (2013) (9)
Successful management of severe chylothorax with argon plasma fulguration and fibrin glue in a premature infant. (2003) (9)
Virilising 21-Hydroxylase Deficiency: Timing of Newborn Screening and Confirmatory Tests can be Crucial (1999) (9)
Measurement of plasma ketoprofen by a rapid high-performance liquid chromatography assay. (1997) (9)
Measurement of Whole Blood Sirolimus by an HPLC Assay Using Solid-Phase Extraction and UV Detection (2002) (9)
Identifying duplicate publications: primum non nocere. (2008) (9)
Insight into infection‐mediated prostate damage: Contrasting patterns of C‐reactive protein and prostate‐specific antigen levels during infection (2017) (9)
Animal olfactory detection of disease: promises and pitfalls. (2014) (9)
Racial Variation in Umbilical Cord Blood Leptin Concentration in Male Babies (2010) (9)
Organic Acids Interfere in the Measurement of Carbon Dioxide Concentration by the Kodak Ektachem 700 (1992) (9)
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus (2004) (8)
The changing face of laboratory medicine: a more service and less academically oriented profession? (2015) (8)
Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months (2015) (8)
Apolipoprotein and lipoprotein cholesterol concentrations in trained and sedentary males. (1987) (8)
Nonfasting Low-Density Lipoprotein Testing: Utility for Cholesterol Screening in Pediatric Primary Care (2007) (8)
Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors (2019) (8)
Immunoturbidimetric Measurement of Serum Retinol-Binding Protein in Renal and Hepatic Disease (1988) (7)
Declining blood lead and zinc protoporphyrin levels in Ecuadorian Andean children. (2013) (7)
Preanalytic and Analytic Sources of Variations in C-Reactive Protein Measurement (2003) (7)
Standardization of lipoprotein reporting. (2000) (7)
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis (2022) (7)
Measurement of trazodone using solid-phase extraction and wide-bore capillary gas chromatography with nitrogen-selective detection. (1988) (7)
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole. (1995) (6)
Control and Prevention and the American Heart Association Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public (2012) (6)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Statement by the Consortium of Laboratory Medicine Journal Editors (2012) (6)
Serum retinol-binding protein and creatinine in onset of and recovery from acute renal failure. (1987) (6)
Immunoturbidimetric assay of transferrin: effect of iron and need for serum blanks. (1986) (5)
Role of the clinical laboratory in evaluation of argininosuccinate lyase deficiency. (1991) (5)
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors (2011) (5)
Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men (2014) (5)
Radiation-associated risk factors for premature cardiovascular disease in childhood cancer survivors include accelerated atherosclerosis (2003) (5)
Insulin Sensitivity and Insulin Secretion Determined by the Homeostasis Model Assessment (HOMA) and Risk of Diabetes Mellitus in a Multi-Ethnic Cohort of Women: The Women’s Health Initiative Observational Study (2007) (5)
Immunoturbidimetry of transthyretin (prealbumin) in human serum. (1987) (5)
Statistical methods for test and biomarker evaluation studies: a clinical chemistry series. (2012) (5)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports (2012) (5)
Correlations of cardiovascular disease risk factors between African American siblings. (2000) (4)
Adipocytokines , In fl ammation , and Breast Cancer Risk in Postmenopausal Women : A Prospective Study (2013) (4)
Triangulating Dynamic of Clinical Laboratory Testing. (2015) (4)
Development of a radioreceptor assay to measure glucocorticoids. (1992) (4)
Immunoturbidimetry of beta 2-microglobulin in serum. (1989) (4)
Advancing laboratory medicine through innovation: a tale of six inventors. (2012) (4)
Effects of Long-Term Haemodialysis on Lipid, Lipoprotein and Apolipoprotein Levels of Black Patients with Chronic Renal Failure (1988) (4)
Biochemical effects of 17 beta-estradiol on UMR106 cells. (1989) (4)
Multigrain Healthy Cookies for Diabetes Mellitus (2016) (4)
Maintaining Research and Publication Integrity. (2019) (4)
Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg 2 1 method (1998) (4)
C-Reactive Protein and Risk of Colon Cancer—Reply (2004) (3)
High-sensitivity C-reactive protein and cardiovascular disease. (2008) (3)
The effects of the behavioral patterns on lipoprotein profile. (1987) (3)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports (2012) (3)
Lead poisoning in young children in Washington, DC: a crisis that remains to be addressed. (1992) (3)
Women : The Reynolds Risk Score the Assessment of Global Cardiovascular Risk in Development and Validation of Improved Algorithms for Supplementary material (2007) (3)
Intrafamilial relations of cardiovascular disease risk factors in African-Americans: longitudinal results from DC SCAN. (1999) (3)
Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis (2019) (3)
Full disclosure in industry-sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors. (2011) (3)
Automated determination of apolipoprotein AI and apolipoprotein E in cerebrospinal fluid. (1986) (3)
Does Clinically Unsuspected Myocardial Injury Occur in Children? † 589 (1997) (3)
Abstract 977: Baseline Troponin Levels Predict 30 Day CV Mortality in STEMI Independent of Clinical and Electrocardiographic Factors: Analysis from CLARITY-TIMI 28 (2008) (2)
Inflammation and Age-Related Macular Degeneration—Reply (2004) (2)
408-2 Cardiac troponin elevations in marathon runners: Prevalence and risk factors (2004) (2)
Learning in the 21st Century: Concepts and Tools. (2018) (2)
Association Between C–Reactive Protein and Lutein/Zeaxanthin, Fish Intake, Body Mass Index and Other Age–Related Macular Degeneration Risk Factors (2005) (2)
Full disclosure in industry‐sponsored laboratory medicine research studies: statement by the consortium of laboratory medicine journal editors (2012) (2)
Abstract 20432: Diagnostic Value of Cardiac Troponin T, N-Terminal Pro-Brain Natriuretic Peptide, and High-Sensitivity C-Reactive Protein During Doxorubicin Therapy in Children with Acute Lymphoblastic Leukemia (2010) (2)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. (2012) (2)
Communication of scientific information: is it time to reassess? (2013) (2)
Plasma Concentration of Cystatin-C and Mannose Binding Protein and the Risk of Developing Peripheral Vascular Disease (2001) (2)
Is C-Reactive Protein Specific for Vascular Disease in Women? (2002) (2)
Myocardial Infarction The Prognostic Value of Serum Myoglobin in Patients With Non – ST-Segment Elevation Acute Coronary Syndromes Results From the TIMI 11 B and TACTICS-TIMI 18 Studies (2016) (2)
Assessment of the Immunoreactivity of Digoxin Metabolites and the Cross‐Reactivity with Digoxin‐Like Immunoreactive Factors in the Roche‐TDM ONLINE Digoxin Assay (1995) (2)
A Randomized Trial and Cohort Study (PRINCE): The Pravastatin Inflammation/CRP Evaluation Effect of Statin Therapy on C-Reactive Protein Levels: (2008) (2)
Clinical Chemistry: A Greater Emphasis on Proteomics (2010) (2)
Relation between Serum Troponin Levels and Cardiovascular Status in Children and Young Adults with Chronic Renal Failure (1999) (2)
Colloquium on rethinking the future of scientific communication. (2012) (1)
Abstract 2550: N-terminal Pro-brain Natriuretic Peptide-defined Cardiomyopathy in Doxorubicin-treated Children with Acute Lymphoblastic Leukemia (2007) (1)
The relationship between severity of peripheral arterial disease and markers of inflammation (2003) (1)
Association of C-peptide concentration with prostate cancer incidence in a prospective cohort (2007) (1)
Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk 1 – 3 (1)
HYPERLIPEMIC RESPONSES OF YOUNG TRAINED AND UNTRAINED MALES FOLLOWING A HIGH PAT MEAL (1986) (1)
Full‐disclosure in industry‐sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors (2011) (1)
Elevated CK-MB Does Not Reliably Indicate Myocardial Injury During Intravenous Terbutaline Therapy for the Treatment of Status Asthmaticus† 186 (1998) (1)
Clinical chemistry and coagulation Editorial comment (1994) (1)
Measurement of methsuximide and N-desmethylmethsuximide using solid-phase extraction and wide-bore capillary gas chromatography. (1988) (1)
An Appeal to Medical Journal Editors: The Need for a Full Description of Laboratory Methods and Specimen Handling in Clinical Study Reports (2012) (1)
Elevated serum myoglobin is associated with increased long-term mortality, independent of cardiac troponin I, electrocardiographic variables, and other baseline variables: combined analyses from TIMI 11B and TACTICS/TIMI 18 (2002) (1)
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. (2011) (1)
Analytic Issues for Clinical Use of C-Reactive Protein (2006) (1)
Clinical Chemistry's Commitment to Education: Stronger than Ever. (2017) (1)
Clinical chemistry and coagulation. (1994) (1)
Evaluation of the APEC analyzer for whole blood glucose. Testing in a pediatric setting. (1995) (1)
Response to Letter Regarding Article, “Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women” (2009) (1)
A Message to Medical School Promotion Committees: Proper Credit for Peer-Reviewed Online Educational Materials. (2019) (1)
Further evidence for the heterogeneity of high density lipoprotein isolates: HDL2:HDL3 cholesterol ratios and the presence of apolipoprotein B. (1987) (1)
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. (2011) (1)
Abstract 814: The Association of Vitamin D With Cardiovascular Disease and Osteopenia May Be Mediated Through a Vitamin D-Sex Steroid Hormone Interaction: Results From the Third National Health and Nutrition Examination Survey (NHANES-III) (2009) (1)
Nutritional Epidemiology Consumption of ( n-3 ) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Activation in Women 1 (2004) (1)
DAILY VITAMIN SUPPLEMENTATION PRIOR TO ULTRAENDURANCE EXERCISE 485 (1996) (0)
Biomarkers of Inﬂammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease: A Cohort Study (2007) (0)
Abstract 15668: Longitudinal Changes in High Sensitivity Troponin T and Pro-B-Type Natriuretic Peptide Over Two Post-Transplant Years in Rejection-Free Pediatric Heart Recipients (2014) (0)
(256) - Left Atrial Function During the First Year After Pediatric Heart Transplantation (2017) (0)
Interpretation of Alvin Coburn's Ezra in pen and ink. (2015) (0)
Interactions between the 514C3T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations (2005) (0)
Abstract 2256: Increased Monocyte Activation Detected By Serum Neopterin and Long-Term Risk in Patients with Acute Coronary Syndromes: Analysis From PROVE IT-TIMI 22 (2006) (0)
Abstract 884: Effects of a Low-Fat Diet and Nutritional Supplements on Inflammatory Markers of Atherosclerosis in Hyperlipidemic Children: The EARLY Trial (2009) (0)
Successful management of severe chylothorax with argon fulguration and fibrin glue in a premature infant (2001) (0)
Cholesterol testing in the physician's office: accuracy assessment. (1991) (0)
Naloxone Produces a Positive Urine Opiate Screen (1999) (0)
Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors (2011) (0)
ociation between C-Peptide Concentration and Prostate Pr R cer Incidence in the CLUE II Cohort Study (2010) (0)
Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men (2014) (0)
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. (2011) (0)
POSITIVE INTERFERENCE. AUTHOR'S REPLY (1992) (0)
Racial variation in steroid hormone and growth factor concentration: US African-American and white female newborns (2007) (0)
International Year of Chemistry 2011: Clinical Chemistry celebrates. (2010) (0)
Abstract 2656: Copeptin Predicts Cardiovascular Death in STEMI Independent of Clinical Factors and NT-proBNP (2008) (0)
Abstract 2259: Risk of Death and Beneficial Effects of Statins in Acute Coronary Syndromes Related to Inflammatory Markers in the MIRACL Study (2006) (0)
Clinically Occult Cardiac Abnormalities in Acutely III Children (1999) (0)
Abstract A83: Organophosphate pesticides and sex steroid hormones in NHANES III (2008) (0)
Clinical Chemistry Views and Policy on Preprints. (2018) (0)
Abstract 2989: Risk of Stroke After Acute Coronary Syndromes In The MIRACL Study Related to Baseline Inflammatory Markers (2006) (0)
Abstract 19867: Fasting Ghrelin, Body Mass Index and Risk of Incident Diabetes in Women (2010) (0)
C-Reactive protein and risk of colon cancer. Authors' reply (2004) (0)
A receptor assay for serum low density lipoprotein-apolipoprotein B-100: preliminary report. (1992) (0)
Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies (2015) (0)
P2-Microglobulin andNeopterin: Predictive Markers forHuman Immunodeficiency VirusType1Infection inChildren? (1990) (0)
Long-Term Prognostic Value of Neopterin A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome Coronary Heart Disease (2007) (0)
A prospective study of plasma adiponectin levels and prostate cancer risk and survival. (2006) (0)
Racial variation in vitamin D cord blood concentration in white and black male neonates (2012) (0)
analysisin premenopausal women: ROC curve Anthropometry, CT, and DXA as predictors of GH (2015) (0)
P Peripheral Vascular Disease Elevated Levels of Inflammation , D-Dimer , and Homocysteine Are Associated With Adverse Calf Muscle Characteristics and Reduced Calf Strength in Peripheral Arterial Disease (2007) (0)
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein Clinical Investigation and Reports (1999) (0)
Abstract 3204: Assessment of Adiponectin and the Risk of Recurrent Cardiovascular Events: Observations from the PROVE IT-TIMI 22 Trial (2008) (0)
Abstract 4468: Pre-diagnostic steroid hormone levels and risk of testicular germ cell tumors (2012) (0)
Abstract 3076: Elevated levels of Placental Growth Factor (PlGF) and Long Term Risk in Patients with Acute Coronary Syndrome in PROVE IT-TIMI 22 (2006) (0)
C-reaktives Protein in der Risikovorhersage und Intervention bei kardiovaskulären Erkrankungen/C-Reactive Protein for Risk Prediction and Intervention in Cardiovascular Disease (2003) (0)
PLASMA VITAMIN A LEVELS ARE DEPRESSED IN ACUTE EXACERBATIONS OF CYSTIC FIBROSIS (1995) (0)
Abstract A96: Association of leptin with sex steroid hormones, insulin, and CRP among adult men in NHANES III (2008) (0)
227-S: Association Between Plasma C-Reactive Protein Concentration and Subsequent Breast Cancer (2005) (0)
Roleof the ClinicalLaboratoryin Evaluationof Argininosuccinate LyaseDeficiency (1991) (0)
Association between c-reactive protein and age-realted macular degeneration (2004) (0)
CHAPTER 26 – Validation of Candidate Protein Biomarkers (2009) (0)
1042-86 Risk stratification in ST-segment elevation myocardial infarction with multiple biomarkers (2004) (0)
91229442 Effects of exercise training on cardiovascular function and plasma lipid, lipoprotein, and apolipoprotein concentrations in premenopausal and postmenopausal women (1992) (0)
C-reactive protein and the risk of colorectal adenoma in CLUE II. (2006) (0)
ORIGINAL COMMUNICATION Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers (2005) (0)
Abstract 12536: A Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women with and without Diabetes: The Women's Health Study (2010) (0)
A Statement for Healthcare Professionals From the Markers of Inflammation and Cardiovascular Disease: Application to Clinical (2003) (0)
Clinical chemistry trainee council: a new journal initiative. (2011) (0)
Protracted AnemiaAssociated withChronic, Relapsing Systemic Inflammation Induced byArthropathic Peptidoglycan-Polysaccharide Polymers inRats (1989) (0)
Plenary Lectures (2006) (0)
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events An 8-Year Follow-Up of 14 719 Initially Healthy American Women Clinical Investigation and Reports (2003) (0)
Dexrazoxane is cardioprotective against doxorubicin cardiotoxicity (2002) (0)
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial. (2023) (0)
Early Dynamic Risk Stratification with Baseline Troponin Levels and 90-minute ST Segment Resolution to Predict 30 Day Cardiovascular Mortality in STEMI: Analysis from CLARITY TIMI-28 (2010) (0)
enoxaparin in unstable angina: a TIMI-11B substudy Cardiac troponin I for stratification of early outcomes and the efficacy of (2009) (0)
Authors' Reply (1992) (0)
Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men (2012) (0)
Comparison of Effectiveness of Implantable Cardioverter Defibrillator in Patients With Idiopathic Dilated Cardiomyopathy Versus Those With Proved Coronary Heart Disease (2003) (0)
Interpretation of Man Ray's Portrait of a Poet in Pen and Ink (2012) (0)
Effect of pravastatin on low-density lipoprotein particle concentration as determined by nuclear magnetic resonance spectroscopy: Results from the pravastatin inflammation/CRP evaluation (PRINCE) trial (2003) (0)
Abstract 1724: Elevated Levels of the Atherosclerotic Lesion Metalloproteinase PAPPA Are an Independent Predictor of Cardiovascular Death or CHF in STEMI: Results from the CLARITY-TIMI 28 Biomarker Study (2007) (0)
Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors (2019) (0)
likely to reduce medical utilization. (2017) (0)
Occult myocardial injury in otherwise healthy newborns (2003) (0)
Abstract 3982: Lipoprotein(a), Hormone Replacement Therapy and the Risk of Future Cardiovascular Disease in Women (2006) (0)
Abstract P102: Circulating Adipocytokines and Risk of Chronic Kidney Disease (2012) (0)
Interpretation of Jo Ractliffe's Drying fish on the beach at Ilha in Pen and Ink. (2016) (0)
as Predictors of Sudden Cardiac Death Prospective Study of C-Reactive Protein , Homocysteine , and Plasma Lipid Levels (2002) (0)
Cardiac troponin T as a biomarker for monitoring chronic doxorubicin cardiomypathy (1999) (0)
- Type Natriuretic Peptide at resentation and Prognosis in Patients ith ST-Segment Elevation Myocardial Infarction n ENTIRE – TIMI-23 Substudy essica (2016) (0)
Measurementof Felbamateby Wide-BoreCapillaryGas Chromatography and Flame IonizationDetection (1994) (0)
CommonPolymorphisms in theAdiponectin and ItsReceptor Genes, Adiponectin Levels and the Risk of Prostate Cancer (2011) (0)
Echocardiographic (Echo) monitoring of myocardial injury during doxorubicin (DOX) therapy for childhood acute lymphoblastic leukemia (ALL). (2004) (0)
Plasma folate, vitamins B6, B12, and homocysteine and pancreatic cancer risk in four large cohorts. (2006) (0)
Abstract CN02-04: Racial/ethnic differences in the association between body composition/fat distribution and circulating hormones and metabolic factors in U.S. men (2009) (0)
Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates (2012) (0)
Original Article Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men (2010) (0)
Abstract 1921: Body fatness and sex steroid hormone concentrations in US men – Results from NHANES III (2011) (0)
NT-PROBNP AND THE RISK OF INCIDENT DIABETES IN WOMEN (2011) (0)
Normal homocysteine levels in a population of children with inflammatory bowel disease. (2005) (0)
Abstract A133: Racial/ethnic differences in serum sex steroid hormone concentrations in a nationally representative sample of U.S. adolescent males (2010) (0)
Abstract P012: Cardiac Biomarkers of Newborn Myocardial Injury, Cardiomyopathy and Inflammation are Associated with Indicators of Premature Cardiovascular Disease in Childhood: The National Institutes of Health Project VIVA Study (2012) (0)
AACC Learning Lab for Laboratory Medicine on NEJM Knowledge+: Clinical Chemistry Recognizes the Contributors. (2018) (0)
Interpretation of Alvin Coburn's The Bridge, Venice in pen and ink. (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nader Rifai?

Nader Rifai is affiliated with the following schools:

Nader Rifai's Academic­Influence.com Rankings

Why Is Nader Rifai Influential?

Nader Rifai's Published Works

Published Works

What Schools Are Affiliated With Nader Rifai?

Nader Rifai's AcademicInfluence.com Rankings